Return to Listing

1 result(s) for

PI Name Protocol # Title
Joseph Shatzel STUDY00018976 A Phase II study of Xisomab 3G3, a monoclonal antibody preventing the activation of FXI by FXIIa, for the prophylaxis of PICC line-associated thrombosis.
 
For more information:
Email: trials@ohsu.edu
Call: 503-494-1080